Siltuximab Clinical Trials
7 recruitingDrug
Phase 25Phase 12Phase 31
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
B-cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLC340 enrolled3 locationsNCT07570173
Recruiting
Phase 2
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Multiple Myeloma
Memorial Sloan Kettering Cancer Center215 enrolled7 locationsNCT06679829
Recruiting
Phase 2
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Pain, ChronicSchwannomatosisSchwannomas
Massachusetts General Hospital40 enrolled1 locationNCT05684692
Recruiting
Phase 2
Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
Hematopoietic and Lymphatic System NeoplasmAdvanced Malignant Solid Neoplasm
Yuanquan Yang40 enrolled1 locationNCT06470971
Recruiting
Phase 1
A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
Antibody Mediated Rejection of Lung Transplant
Washington University School of Medicine30 enrolled2 locationsNCT06990711
Recruiting
Phase 2
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
MyelomaCRS - Cytokine Release Syndrome
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT07106671
Recruiting
Phase 1
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Non-Hodgkin LymphomaCytokine Release Syndrome
Taylor Brooks20 enrolled1 locationNCT06447376